+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Voriconazole"

From
Aspergillosis Treatment Global Market Report 2024 - Product Thumbnail Image

Aspergillosis Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
Otomycosis - Pipeline Insight, 2024 - Product Thumbnail Image

Otomycosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Invasive Aspergillosis - Pipeline Insight, 2024 - Product Thumbnail Image

Invasive Aspergillosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
Antifungal Drugs: Technologies and Global Markets 2021-2026 - Product Thumbnail Image

Antifungal Drugs: Technologies and Global Markets 2021-2026

  • Report
  • November 2021
  • 295 Pages
  • Global
From
From
From
From
Keratitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Keratitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 90 Pages
  • Global
From
Loading Indicator

Voriconazole is an antifungal medication used to treat a variety of fungal infections, including those caused by Aspergillus and Candida species. It is a member of the triazole class of antifungal drugs, and is commonly used in the treatment of serious fungal infections in immunocompromised patients. Voriconazole is also used to treat infections caused by other fungi, such as Fusarium and Scedosporium species. Voriconazole is available in both oral and intravenous formulations, and is generally well tolerated. Common side effects include visual disturbances, rash, and nausea. It is important to note that voriconazole can interact with other medications, and should be used with caution in patients with liver or kidney disease. Voriconazole is a key player in the infectious diseases drugs market, and is used to treat a variety of fungal infections. It is an important treatment option for immunocompromised patients, and is generally well tolerated. Some companies in the voriconazole market include Pfizer, Novartis, Merck, and Astellas Pharma. Show Less Read more